Switching to systemic therapy after locoregional treatment failure: Definition and best timing

In patients with unresectable hepatocellular carcinoma (HCC) without both macrovascular invasion and extrahepatic metastasis, the initial treatment choice recommended is transarterial chemoembolization (TACE). Before sorafenib came into wide use, TACE had been pointlessly carried out repeatedly. It...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogasawara, Sadahisa, Ooka, Yoshihiko, Koroki, Keisuke, Maruta, Susumu, Kanzaki, Hiroaki, Kanayama, Kengo, Kobayashi, Kazufumi, Kiyono, Soichiro, Nakamura, Masato, Kanogawa, Naoya, Saito, Tomoko, Kondo, Takayuki, Suzuki, Eiichiro, Nakamoto, Shingo, Tawada, Akinobu, Chiba, Tetsuhiro, Arai, Makoto, Kato, Jun, Kato, Naoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160341/
https://www.ncbi.nlm.nih.gov/pubmed/31937081
http://dx.doi.org/10.3350/cmh.2019.0021n

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160341/
https://www.ncbi.nlm.nih.gov/pubmed/31937081
http://dx.doi.org/10.3350/cmh.2019.0021n

Ejemplares similares